Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the Cytuity in Determining the Presence of Malignancy

NCT03593681 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03593681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03593681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the Cytuity in Determining the Presence of Malignancy
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
August 27, 2018
Completion date
February 14, 2020
Enrollment
150 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

adnexal mass, fallopian tube adenocarcinoma, fallopian tube cancer, fallopian tube neoplasms, high grade serous carcinoma, ovarian cancer, ovarian diseases, ovarian neoplasms, ovary cancer, peritoneal carcinoma, peritoneal neoplasms